GovChime
AWARDDEFINITIVE CONTRACTSmall business

Definitive contract 75F40123C00073KAIVA STRATEGIES, LLC

Overview

Award facts

Net obligations
$8.99M
$8,989,194of $8.99M potential value
Outlays (paid to date)
$8.99M
$8.99M paid of $8.99M obligated$8,989,194
Period of performance
Sep 5, 2023 to Jun 24, 2025
Ended
Modifications
9
Latest action Jun 16, 2026
Contract type
Definitive contract
PIID 75F40123C00073

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

UEI: HCWKVFGBPA64 LABOR HOUR AWARD CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) OFFICE OF NEW DRUGS (OND) - WRITER/EDITOR SUPPORT SERVICES COR: NIKISHA REID PHONE: 240-402-9741, NIKISHA.REID@FDA.HHS.GOV NOTICE TO PROCEED WAS ISSUED ON 05/30

Dates and value

Award date
Signed on Sep 5, 2023
Current value
$8,989,194Base and exercised options
Potential value (if all options are exercised)
$8,989,194

Obligations by fiscal year of action

  • FY2026: -$605,288 (de-obligation)
  • FY2025: $2,239,502
  • FY2024: $4,917,439
  • FY2023: $2,437,541

Total across 4 fiscal years: $8,989,194

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jun 16, 2026. View on USAspending · Recipient on SAM.gov

Recipient

LocationIVINS, UT
UEIHCWKVFGBPA64
CAGE code99AZ4
Business sizeSmall businessSize at award, per the contracting officer
Parent companyKAIVA STRATEGIES LLC

Business types and certifications

Minority-ownedSelf-certified small disadvantaged business8(a) joint ventureTribally owned firmFor-profit organizationLimited liability company

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Funded by
  1. Department of Health and Human Services
  2. Food And Drug Administration
  3. FDA OFFICE OF ACQ GRANT SVCS
Funded from
Coronavirus emergency funding supplemental; Fda user fees (non general fund)Program activities075-0600Federal accounts (agency financial reports)

Place of performance

Place of performance
Rockville, Montgomery County, Maryland 20857-0001
Congressional district (place of performance)
MD-08As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Not available for competitionB
Reason not competed
Authorized by statute (FAR 6.302-5(A)(2)(I))OTH
Solicitation procedures
Only one sourceSSS
Set-aside
8(a) sole source8AN
Contract pricing
Labor hoursZ
Offers received
1

Contract details

Subcontracting plan
Plan not requiredB
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
No
Commercial procedures
Commercial products/servicesA
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Sep 5, 2023Base obligation at award: $2,437,541
Latest action
Jun 16, 2026 — CloseoutModification P00009; obligation change -$605,288; administrative: no change in scope or value
Latest substantive action
Dec 17, 2024 — Option exercisedModification P00003; obligation change +$2,239,502
Actions by type
  • Base award1
  • Other administrative action6
  • Option exercised2
  • Closeout1
10 actions recorded, Sep 5, 2023 to Jun 16, 2026; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Simplified procedures for commercial items
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$605,288
Latest action: change in base and all options
-$605,288

Socio-economic and policy

Inherently governmental functions
Closely associated,critical functionsCL,CT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7524
Contracting office code
75F401
Transactions recorded under this award key
10

Funding

Funding agency code
7500
Funding sub-tier code
7524
Funding office code
75F401
Treasury accounts
  • 075-X-0600-000
Object classes
  • 25.2: Other services from non-Federal sources
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
  • V: Non-emergency P.L. 117-2
COVID-19 supplemental obligations
$1,171,895
COVID-19 supplemental outlays
$1,171,895